Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
ACTEMRA Inj Lös 162 mg/0.9ml Fertspr 4 Stk
Drug
Actemra, Injektionslösung zur subkutanen Anwendung
Rheumatoide Arthritis, Riesenzellarteriitis, polyartikuläre juvenile idiopathische Arthritis, systemische juvenile idiopatische Arthritis
07.15.0. – immunosuppressants
HAM – Human medicine
LSPA – Parenteral solution
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
9/12/2014
12/31/9999
Dosage strength
Actemra 162 mg/0.9 ml, Injektionslösung zur subkutanen Anwendung
Rheumatoide Arthritis, Riesenzellarteriitis, polyartikuläre juvenile idiopathische Arthritis, systemische juvenile idiopatische Arthritis
01
Z – approved
Package
7680631660014
No information made available
A/R – Authorised / referenced
4 pre-filled syringe(s)
001
Z – approved
Declaration
Component
162 mg tocilizumabum
polysorbatum 80
arginini hydrochloridum
methioninum
histidinum
histidini hydrochloridum monohydricum
aqua ad iniectabile
arginini hydrochloridum
methioninum
histidinum
histidini hydrochloridum monohydricum
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
1063.70
None
Yes
10%
No
Authorisation holder
7601001010208
Roche Pharma (Schweiz) AG
Grenzacherstrasse 124
4058 Basel (BS)
Grenzacherstrasse 124
4058 Basel (BS)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.